Colesevelam

Revision as of 15:53, 26 March 2014 by ShiSheng (talk | contribs)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

For patient information about Colesevelam, click here.

Synonyms / Brand Names: Welchol®

Overview

Colesevelam is a bile acid sequestrant administered orally. It is developed by Genzyme and marketed in the US by Daiichi Sankyo under the brand name Welchol and elsewhere by Genzyme as Cholestagel. In Canada it is marketed by Valeant as Lodalis.

Category

Bile acid sequestrant

Prescribing Information

Colesevelam hydrochloride

Template:Lipid modifying agents